A World Without Antibiotics. Empowering wellness with spore-based probiotics for a healthier tomorrow.
In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences.
We build a happy working environment where all members are given equal opportunities and are created with equal favourable conditions to realize their dreams towards realizing the shared dream. “For an antibiotic-free future for everyone.” Each of the prominent LiveSpo people has a viable “gene” template with unique properties:
LiveSpo is an R&D, manufacturing, and distribution brand of Spobiotics (probiotics in spore form) for digestive and respiratory health, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for “A Future Without Antibiotics”. The Company structure of LiveSpo includes: